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OBJECTIVE — To determine whether circulating metabolic intermediates are related to in-
sulin resistance and -cell dysfunction in individuals at risk for type 2 diabetes.
RESEARCH DESIGN AND METHODS — In 73 sedentary, overweight to obese, dys-
lipidemicindividuals,insulinactionwasderivedfromafrequentlysampledintravenousglucose
tolerance test. Plasma concentrations of 75 amino acids, acylcarnitines, free fatty acids, and
conventional metabolites were measured with a targeted, mass spectrometry–based platform.
Principal components analysis followed by backward stepwise linear regression was used to
explore relationships between measures of insulin action and metabolic intermediates.
RESULTS — The75metabolicintermediatesclusteredinto19factorscomprisingbiologically
related intermediates. A factor containing large neutral amino acids was inversely related to
insulin sensitivity (SI)( R
2  0.26). A factor containing fatty acids was inversely related to the
acute insulin response to glucose (R
2  0.12). Both of these factors, age, and a factor containing
medium-chain acylcarnitines and glucose were inversely and independently related to the dis-
positionindex(DI)(R
20.39).SexdifferenceswerefoundformetabolicpredictorsofSIandDI.
CONCLUSIONS — In addition to the well-recognized risks for insulin resistance, elevated
concentrations of large, neutral amino acids were independently associated with insulin resis-
tance. Fatty acids were inversely related to the pancreatic response to glucose. Both large neutral
amino acids and fatty acids were related to an appropriate pancreatic response, suggesting that
these metabolic intermediates might play a role in the progression to type 2 diabetes, one by
contributing to insulin resistance and the other to pancreatic failure. These intermediates might
exert sex-speciﬁc effects on insulin action.
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W
ith people in developed coun-
tries becoming increasingly less
active and more obese, the inci-
dence of type 2 diabetes is growing at an
alarming rate. Given the critical role of
skeletal muscle in glucose disposal, much
work has focused on understanding skel-
etalmuscleinsulinresistance.Inaddition,
because progression to overt type 2 dia-
betes requires defective pancreatic -cell
secretion of insulin (1), efforts are also
underway to dissect the mechanisms of
pancreatic -cell failure. Prevailing theo-
ries for insulin resistance focus on lipid-
mediated mechanisms but also include
insulin resistance mediated by elevated
concentrationsofaminoacidsandinﬂam-
matory signaling molecules as well as
combinations of these (2). Similarly,
-cell dysfunction leading to type 2 dia-
betes has been linked to cellular stress re-
sponses triggered by overstimulation of
insulin synthesis and secretion, as well as
the effects of lipid mediators to cause
changes in key metabolic activities of
-cells that impair control of insulin se-
cretion (2).
Most of these hypotheses have re-
volved around elegant physiological in-
vestigations often performed in animal
models.However,althoughthesephysio-
logical investigations provide great in-
sight into mechanisms, they do not
conclusively illustrate that such mecha-
nisms function at the population level in
humans. Using a well-characterized sam-
ple from a clinical trial, our objective was
todeterminewhetherthemeasurementof
metabolic intermediates with a targeted,
massspectrometry–basedplatformmight
provide insight into the pathogenesis of
insulin resistance, a harbinger and essen-
tial component of type 2 diabetes. Our
hypothesis was that in this group of men
and women at risk for, but without, overt
type 2 diabetes, lipid mediators would be
related to insulin resistance and hyper-
glycemia would be related to -cell
dysfunction.
RESEARCH DESIGN AND
METHODS— This was a cross-
sectional evaluation of the relationship
between concentrations of circulating
metabolic intermediates and insulin ac-
tion in 73 subjects who enrolled in the
ﬁrst and second Studies of Targeted Risk
Reduction Interventions through Deﬁned
Exercise (STRRIDE). Inclusion criteria
were age between 18 and 70 years, inac-
tivity (not participating in regular exer-
cise), being overweight to mildly obese
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2), dyslipidemia (LDL
cholesterol 130–190 mg/dl or HDL cho-
lesterol 40 mg/dl for men and 45
mg/dl for women), and postmenopausal
status for women. Exclusion criteria in-
cluded diagnosed diabetes or fasting glu-
cose 126 mg/dl, medications known to
affectcarbohydrateorlipidmetabolism,a
dietary regimen designed to induce
weightloss,hypertension(bloodpressure
160/90 mmHg), known cardiovascular
disease,tobaccouse,andmusculoskeletal
conditions prohibiting exercise training
(3).
Circulating metabolite
measurements
Fasting EDTA plasma was collected from
each participant and stored at 80°C.
Circulatingmetabolitesweremeasuredin
plasma from 73 subjects at study enroll-
ment. Fifteen amino acids, 45 acylcar-
nitines, and 9 free fatty acids were
measured using a targeted, mass spec-
trometry–based platform as described
previously(4,5).Inbrief,aminoacidsand
acylcarnitines were methanol precipi-
tated, esteriﬁed, and analyzed with
tandem mass spectrometry. After methyl-
ation with iodomethane and partial puri-
ﬁcation, free fatty acids were measured
with gas chromatography/mass spec-
trometry. Conventional metabolites in-
cluding glucose, lactate, uric acid, total
ketones, -hydroxybutyrate, and nonest-
eriﬁedfreefattyacidsweremeasuredwith
colorimetric enzymatic assays using a Hi-
tachi 911 analyzer (4). Reagents for Hita-
chi analyses were obtained from Roche
(Indianapolis, IN; glucose, lactate, and
uric acid) and Wako USA (Richmond,
VA; total ketones, -hydroxybutyrate,
and nonesteriﬁed free fatty acids).
Metabolic and cardiovascular risk
factor assessments
Afrequentlysampledintravenousglucose
tolerance test was performed in all sub-
jects. Fasting insulin (Access Immunoas-
say System; Beckman Coulter, Fullerton,
CA) and fasting glucose (YSI2300 STAT
Plus; YSI, Yellow Springs, OH) were mea-
sured. Using these concentrations, insu-
lin sensitivity (SI) and the acute insulin
response to glucose (AIRg) were derived
basedonBergman’sminimalmodel(3,6).
The disposition index (DI) was calculated
as the mathematical product of insulin
sensitivity index and AIRg (SI  AIRg).
Data analysis
Our main objective was to determine
whether metabolic intermediates might
be predictive of baseline insulin sensitiv-
ity and insulin action. Given the large
number of predictors relative to the sam-
ple size and collinearity of analytes, prin-
cipal components analysis (PCA) was
used as a means to reduce the complexity
of the variables. Each of the metabolic in-
termediates was logarithmically trans-
formed [log10(metabolite  1)] to
approximate a normal distribution. An
orthogonal varimax rotation was used,
and factors with an eigenvalue 1 were
retained. Individual metabolites with a
factor load of 0.4 for a given PCA-
derived factor are reported as composing
that factor. Given the presence of certain
acylcarnitines having values below the
lower limits of quantiﬁcation, sensitivity
analysesofPCAwereperformedwithand
without metabolites in which 25% of
metabolitevalueswerebelowthelimitsof
quantiﬁcation. Similar results were ob-
tainedwitheach(datanotshown);hence,
models inclusive of all analytes are
presented.
For modeling insulin action compo-
nents (SI, AIRg, and DI) as outcomes, fac-
tors retained in PCA were used in linear
regressionusingbackwardsstepwisevari-
able selection. SI, AIRg, and DI were log-
arithmically transformed before analyses
to approximate a normal distribution,
and analyses were controlled for age, sex,
and waist circumference. To determine
whethersexdifferencesexistforthosefac-
tors found related to insulin action, sex
interactions were evaluated. First, full
models were ﬁt including each of the in-
dependently related factors and each sex-
related factor interaction term. If none of
the sex interaction terms was found to be
signiﬁcant, these terms were removed,
and the main effects model was reﬁt. If
any of the sex interactions were found to
be signiﬁcant, then stratiﬁed main effects
modelswereevaluated.Statisticalanalysis
was performed using SAS Enterprise
Guide (version 8.2; SAS Institute, Cary,
NC) with statistical signiﬁcance estab-
lished as P  0.05.
RESULTS— The mean  SD age of
this study population was 51.2  7.7
years. Of the 73 subjects, 35 (48%) were
women and 38 (52%) were men. Fifty-
eight (79%) were Caucasian, 12 (16%)
were African American, 2 (3%) were
Asian, and 1 (1%) was Hispanic. The me-
dian SI was 2.88 (interquartile range
1.84–5.61)  10
5 min
1/[pmol/l]. The
median AIRg was 354.9 (183.6–529.1)
pmol/l, and median DI was 1,237.3
(583.8–1,732.2)  10
5 min
1. Supple-
mentary Table 1 (available in an online ap-
pendix at http://care.diabetesjournals.org/
cgi/content/full/dc08-2075/DC1) shows
median values and ranges for concentra-
tions of metabolic intermediates.
PCA was used to reduce the large
number of circulating metabolic interme-
diatesintofewer“factors”containingmet-
abolic intermediates that were highly
correlated with one another. Table 1
shows the constituent metabolites for
each of the 19 retained factors. As shown
in Table 1, the metabolic constituents for
eachfactorwerebiologicallyrelated,such
that a biological description for each fac-
tor could be applied (Table 1). The ﬁrst
ﬁve factors represented a majority of the
variance in the dataset and were summa-
rized as factors containing 1) medium-
and long-chain acylcarnitines, 2) fatty
acids and by-products of fatty acid oxida-
tion,3)long-chainacylcarnitinesandace-
tylcarnitine, 4) large neutral amino acids
and uric acid, and 5) medium-chain acyl-
carnitines and glucose.
After reducing the complexity of the
metabolic intermediates into 19 factors of
related metabolites, we sought to deter-
mine whether these factors could predict
SI. Independent of age, sex, and waist cir-
cumference, three of these factors were
associated with SI and accounted for 63%
of its variance (Table 2). Of these three
factors, the one most associated with SI
was the factor containing large neutral
amino acids. Being inversely associated
withSI,thissinglefactorpredicted26%of
the variance in insulin sensitivity (P 
0.0001) (Fig. 1). These ﬁndings are con-
sistentwithanotherrecentstudyfromour
group in which a branched-chain amino
acid (BCAA)–related factor that included
leucine/isoleucine, valine, phenylalanine,
and tyrosine was the one most strongly
associated with a different measure of in-
sulin sensitivity (homeostasis model as-
sessment index) in a cohort of 73 obese
and 67 lean subjects (7). Additional inde-
pendent associations of SI are shown in
Table 2.
When evaluating predictors of pan-
creatic response, we found that indepen-
dent of age, sex, and waist circumference,
a metabolic factor containing fatty acids
and by-products of fatty acid oxidation
was inversely related to AIRg. This model
accountedfor28%ofthevarianceinpan-
creatic response (Table 2), and alone this
Huffman and Associates
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in AIRg (P  0.002) (Fig. 1). Because an
appropriate pancreatic response should
varybasedontissueinsulinsensitivity,we
also sought to better understand predic-
tors of an appropriate pancreatic re-
sponse, as represented by DI. We were
able to explain 39% of the variance in the
DIwithamodelcontainingage,sex,waist
circumference, and three metabolic fac-
tors (Table 2). Inverse associations were
seen for DI and factors containing free
fatty acids (Fig. 1), large neutral amino
acids(Fig.1),andmedium-chainacylcar-
nitines and glucose. In addition, age was
independently and inversely associated
with DI. Body composition, as measured
by waist circumference, was an indepen-
dent predictor of both SI and AIRg, but
not of DI.
We also explored sex differences in
predictors of insulin action because of
previous observations of sex-speciﬁc ef-
fects of metabolic factors on measures of
insulin action. For SI, we observed a sig-
niﬁcant interaction between sex and the
factor composed of glutamine and gluta-
mate, factor 7 (P  0.03). Using sex-
stratiﬁed analyses to further elucidate this
sex interaction (supplementary Table 2,
available in the online appendix), we ob-
served that, for men, waist circumference
and factors 4, 7, and 8 remained signiﬁ-
cant independent predictors of insulin
sensitivity and accounted for 64% of the
variance in SI (model P  0.0001) (sup-
plementary Table 2). However, for
women, factor 7 was not predictive of SI,
whereas waist circumference and factors
4and8remainedindependentpredictors
of SI (model P  0.0001, model R
2 
0.61) (supplementary Table 2).
There was no signiﬁcant interaction
between sex and factor 2 for the relation-
ship with AIRg (P  0.35), and, thus,
stratiﬁed analyses were not performed for
thismeasureofinsulinaction.Wheneval-
uating sex differences in metabolic rela-
tionshipsforDI,weobservedasigniﬁcant
interaction between sex and factor 5 (P 
0.01). In sex-stratiﬁed analyses, factor 4
wastheonlysigniﬁcantpredictorofDIfor
men(modelP0.0001)(supplementary
Table 2). In contrast, in women, factor 4
was not independently related to DI, but
factors 5 and 2 remained signiﬁcant inde-
pendent predictors of DI (model P 
0.0001) (supplementary Table 2).
CONCLUSIONS — Our objective
was to determine whether circulating
metabolic intermediates, as measured
with a mass spectrometry–based plat-
form,areassociatedwithinsulinactionin
a mixed-sex population at risk for, but
without, overt type 2 diabetes. Using a
Table 1—Results of principal components analysis
Factor Metabolites within factor Description
Eigen
value Variance
Cumulative
variance
1 C8 C5-DC C10:1 C10 C12:1 C12 C14:2
C14:1 C14 C16 C8:1-OH/C6:1-DC C8:
1-DC C16:2 C16:1 C18:2
Medium- and long-chain acylcarnitines 13.1 0.17 0.17
2 FA-C14:0 FA-C16:1 FA-C16:0 FA-	-C18:3
FA-C18:2 FA-C18:1 FA-C18:0 FA-C22:6
Free fatty acids Hydroxybutyrate Ketones
C2
Free fatty acids and by-products of fatty acid
oxidation
9.6 0.13 0.30
3 C2 C6-DC C10-OH/C8-DC C12-OH/C10-
DC C14:1-OH C18 C18:1 C18:2 C14-
OH/C12-DC C18:1-OH C16:1-OH/C14:
1-DC C16
Long-chain acylcarnitines and C2-acylcarnitine 6.4 0.09 0.39
4 Proline Valine Leucine/Isoleucine
Methionine Phenylalanine Tyrosine Uric
acid Histidine
Large neutral amino acids and uric acid 4.3 0.06 0.44
5 C8:1 C10:3 Glucose Medium-chain acylcarnitines and glucose 3.5 0.05 0.49
6 C3 C4/Ci4 C5s Short-chain acylcarnitines 3.1 0.04 0.53
7 Glutamate/Glutamine Hydroxybutyrate
Ketones Glucose
Glutamate/Glutamine 2.7 0.05 0.57
8 Glycine Serine One-carbon metabolism 2.3 0.03 0.60
9 C20 C16-OH/C14-DC C18:1-DC Long-chain and hydroxy or dicarboxy acylcarnitines 2.1 0.03 0.63
10 Alanine Lactate Alanine and lactate 2.0 0.03 0.66
11 C6 C5OH/C3-DC Short-chain and hydroxy or dicarboxy acylcarnitine 1.7 0.02 0.68
12 Citrulline Arginine C10:2 C18-OH/C16-DC Urea cycle, medium-chain acylcarnitine, and
hydroxy or dicarboxy acylcarnitine
1.7 0.02 0.70
13 C20:4 Arachidonoyl carnitine 1.5 0.02 0.72
14 Ornithine FA-C20:4 (neg) Ornithine and arachidonic acid 1.5 0.02 0.74
15 C5:1 C18:2-OH (neg) Acylcarnitines 1.6 0.02 0.76
16 C22 C4-OH (neg) Acylcarnitines 1.3 0.02 0.78
17 Aspartate/Asparagine Aspartate/Asparagine 1.3 0.02 0.79
18 C18-OH/C16-DC C22:6 Hydroxy or dicarboxy acylcarnitine 1.2 0.02 0.81
19 Histidine C7-DC Histidine and dicarboxy acylcarnitine 1.1 0.01 0.82
Key metabolites within each retained factor (i.e., metabolites with factor load  0.4) and an overall description of each factor are presented. Italicized metabolites
represent those with a factor load 0.4 on a second factor. DC, dicarboxylic; FA, fatty acid.
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of the large number of metabolic vari-
ables,weobservedseveralcomponentsof
insulin action to be independently opera-
tive in this population. A single factor
containing large neutral amino acids was
inversely related to both SI and DI. In ad-
dition, a factor containing free fatty acids
and by-products of fatty acid oxidation
wasinverselyrelatedtobothAIRgandDI.
Thus, both large neutral amino acids and
fatty acids might contribute to progres-
sion to type 2 diabetes and might exhibit
differential contributions for insulin ac-
tion for each sex.
The potential for amino acids to con-
fer insulin resistance has been recognized
for some time (8). As with many obesity-
related derangements, amino acid–
induced insulin resistance probably
results from mechanisms that have
evolved to operate in a low-calorie, high-
activity environment now functioning in
a high-calorie, low-activity environment
Table 2—Linear regression models for measures of insulin action using backward stepwise
variable selection controlling for age, sex, and waist circumference
Parameter
estimate SEM FP
SI model: R
2
SI  0.63, P  0.0001
Factor 4: Large neutral amino acids and uric acid 0.123 0.027 21.41 0.0001
Waist circumference (cm) 0.014 0.003 16.28 0.0001
Factor 8: Glycine and serine 0.091 0.025 13.57 0.0005
Factor 7: Glutamate/Glutamine (ketones and
glucose) 0.093 0.027 11.95 0.001
AIRg model: R
2
AIRg  0.28, P  0.0002
Factor 2: Fatty acids and by-products of fatty
acid oxidation 0.088 0.043 4.07 0.048
DI model: R
2
DI  0.39, P  0.0001
Factor 4: Large neutral amino acids and uric acid 0.145 0.044 10.56 0.002
Factor 2: Free fatty acids and by-products of
fatty acid oxidation 0.131 0.046 8.06 0.006
Age (years) 0.014 0.006 5.92 0.018
Factor 5: Medium-chain acylcarnitines and
glucose 0.092 0.042 4.83 0.032
Metabolite factors are those that remained signiﬁcant in multivariable regression models. R
2 values reﬂect
values for models presented and include effects of age, sex, and waist circumference. Only signiﬁcant
predictors are presented and individual R
2 values are discussed in text.
Figure1—Relationshipsbetweenfactorscoresandmeasuresofinsulinaction.A:Relationshipbetweenfactor4scoreandSI.B:Relationshipbetween
factor 2 score and AIRg. C: Relationship between factor 4 score and DI. D: Relationship between factor 2 score and DI.
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which high-protein meals are infrequent,
it is not surprising that large neutral
amino acids would promote an anabolic
statebyinhibitingproteolysisanddirectly
stimulating protein synthesis (10). Simi-
larly, elevated concentrations of amino
acids produce insulin resistance by dis-
rupting insulin-mediated glucose uptake
pathways, resulting in reduced glucose
uptake and glycogen synthesis (11). Both
stimulation of protein synthesis and inhi-
bition of insulin-stimulated glucose up-
take occur at the level of the mammalian
target of rapamycin (12), a key nodal
point in signaling for protein synthesis
(13) and insulin-stimulated glucose up-
take(10,12).Thiscoordinatedpromotion
ofproteinsynthesisanddisruptionofglu-
cose uptake pathways would function
well with occasionally elevated amino
acid concentrations. However, in obesity,
elevated concentrations of amino acids
are sustained even in the fasting state (8),
promoting sustained insulin resistance
and, in the presence of other pathological
aberrations, progression to diabetes. Re-
cently, compelling support for the idea
that these elevations could be related to
pathophysiology was provided by ﬁnd-
ings that BCAA and several related amino
acids and metabolites were elevated in
obese, insulin-resistant subjects com-
pared with lean control subjects, and
these concentrations were linearly related
to the homeostasis model assessment in-
dex (7). Further, in rats, a high-fat diet
supplemented with BCAA produced in-
sulin resistance, whereas supplementa-
tion of normal chow did not, and the
insulin resistance provoked by high-fat/
BCAA feeding was reversed with admin-
istration of the mammalian target of
rapamycin inhibitor, rapamycin (7). Al-
though we recognize that other mecha-
nisms of insulin resistance are also
operative with similar teleological expla-
nations, our work clearly supports older
as well as new data that relate insulin re-
sistance and concentrations of large neu-
tral amino acids at the population level
and in a mixed-sex population.
Inadditiontoinsulinresistance,ade-
fective -cell compensatory response is
critical to the development of type 2 dia-
betes. Similar to the detrimental effects of
chronically elevated amino acids on skel-
etal muscle, emerging evidence suggests
that chronic lipid exposure plays a key
role in molecular events culminating in
-cell failure (2). In -cells, lipid oxida-
tion to acetyl-CoA activates pyruvate car-
boxylase and initiates a pyruvate cycle,
which results in an increase in concentra-
tions of molecules that amplify insulin se-
cretion.Thus,inhealthy,fastinghumans,
acutely elevated free fatty acids promote
-cell secretion of insulin to suppress
rampant adipocyte lipolysis and prevent
subsequent ketoacidosis (2). As insulin
resistance develops, elevated concentra-
tions of free fatty acids promote greater
insulin secretion to compensate for
insulin resistance, contributing to the
well-recognized consequence of
hyperinsulinemia. However, sustained
exposure to elevated concentrations of
fatty acids and chronic activation of pyru-
vatecarboxylaseresultsinadampeningof
the response of this pathway to glucose
(2,14) and deﬁcits in -cell insulin secre-
tion (15–17). In addition, this qualitative
defect is probably compounded by -cell
apoptosis and a quantitative reduction in
-cells driven by increased oxidative and
endoplasmic reticulum stress that occurs
as a result of an overload of -cell lipid
metabolism (2,15). We observed that a
factor containing free fatty acids and by-
products of fatty-acid oxidation was in-
versely associated with the acute
pancreatic response and the pancreatic
response when insulin sensitivity is ac-
counted for (DI). Our ﬁndings show that
a poorer compensatory response in insu-
lin production is associated with higher
concentrations of circulating fatty acids,
potentiallysupportingatoxiceffectoflip-
ids on -cells in pre-diabetic subjects
such as those included in the current
study.
In addition to evaluating relation-
shipsbetweencirculatingmetabolitesand
measures of insulin action, we also ex-
ploredsexdifferencesinrelationshipsbe-
tween circulating metabolites and insulin
action. We observed that for men, insulin
sensitivity was most related to the factor
containing large neutral amino acids and
another containing glutamine and gluta-
mate.Forwomen,concentrationsofthese
two sets of metabolites were much less
strongly related to insulin sensitivity, but
waist circumference and a factor contain-
ing glycine and serine were most related.
In addition, the inverse relationship be-
tween concentrations of fatty acids and
the appropriate pancreatic response (DI)
wasmorerobustforwomenthanformen.
Weﬁndthesesexdifferencesintriguingin
light of emerging evidence that supports
sex differences in development of insulin
resistance and diabetes (18). Before ado-
lescence, girls are more insulin resistant
than boys, but during adolescence, a shift
occurssuchthatinadulthood,womenare
more insulin sensitive than men (19).
Whereas several studies have shown that
both male rats (20) and men (21) are
more susceptible than female rats and
women to fatty acid–induced insulin re-
sistance, less work has been focused on
examiningsexdifferencesinrelationships
between amino acids and insulin
resistance.
It is notable that most of the work
examining BCAAs in the context of obe-
sity and insulin resistance has been per-
formed predominantly in men (8,11,13).
In addition, prior investigations have
shown that men are more likely to de-
velop insulin resistance as a consequence
of low birth weight (22) and gestational
proteinavailability(23)andexhibitstron-
ger relationships between the insulin-like
growth factor axis and insulin sensitivity
(24). Such reports led us to hypothesize
that in men, gestational programming,
which is designed to meet greater ana-
bolic demands and that operates under
abundant amino acid exposure later in
life, drives our ﬁndings of a stronger rela-
tionship between amino acid concentra-
tions and insulin resistance. Our ﬁndings
that women might be more susceptible to
-cell lipotoxicity could be related to the
observed sex differences in hormone-
sensitive lipase-mediated regulation of li-
polysis in pancreatic -cells (25). Most
important,theobservedsexdifferencesin
these relationships emphasize the critical
nature of careful attention to sex differ-
encesandhormonalinﬂuencesoninsulin
actioninoureffortstouncoverthepatho-
genesis of type 2 diabetes.
We recognize that this investigation
has several limitations. The moderate
sample size and cross-sectional nature of
this investigation may limit the applica-
bilityofourﬁndings.Althoughthiscross-
sectional design allows only inferences
about causality, we have taken advantage
of this design to conﬁrm the ﬁndings of
prior physiological studies in humans at a
population level. In addition, our moder-
ate sample size did not allow for explora-
tion of race or ethnic variations in
predictors of insulin action. Similarly, we
were unable to account for other obvious
inﬂuences on insulin action such as ge-
netic ones. However, we were able to ex-
plore sex differences in both insulin
resistance and -cell dysfunction. Also,
we were able to demonstrate the applica-
bility of a targeted, mass spectrometry–
based platform to a clinical sample of
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large number of correlations between bi-
ological assays and clinical measure-
ments, we have illustrated that PCA is a
means of data complexity reduction with
biological plausibility.
Thus, in a mixed-sex population at
risk for, but without, overt type 2 diabe-
tes, concentrations of large neutral amino
acids were related to insulin resistance,
and concentrations of free fatty acids and
by-products of fatty acid oxidation were
related to an impaired pancreatic re-
sponse. There was also a sex difference in
the strength of these relationships, such
that men seemed to be more susceptible
to amino acid-induced insulin resistance
and women were more vulnerable to
lipid-mediated -cell toxicity. Although
these ﬁndings merit validation in other
cohorts,theysupporttherecognitionthat
metabolic processes that have evolved to
sustaindemandsinalow-calorieenviron-
ment produce many of the aberrations
characteristic of type 2 diabetes when
metabolic fuels are in excess.
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